A randomized, double-blind, placebo-controlled, multiple-dose trial of the efficacy and safety of a sublingual glutathione wafer (RadianiX™) as a therapeutic skin health supplement.

CONDITION

Skin

GENDER

Females

AGE GROUP

From 30

to 65 years

STATUS

Recruiting

Primary Objective:

To determine the change in the following parameters following administration of RadianiX ™

  1. Skin Melanin Index and Erythema Score
  2. Skin Hyperpigmentation
  3. Skin Elasticity
  4. Visual Skin Properties
  5. Skin Luminosity
  6. Colourimetry

Secondary Objectives:

To investigate the pharmacokinetics of glutathione following RadianiX™ administration

CONTACT DETAILS

Phone Number: 0297193852

Email: trials@oztrials.com

Location: Suite1, 56-56A Thompson Street, Drummoyne NSW, Australia

Approved By: Bellberry Limited              

Clinical Trial Registry Link: Click Here